Anticancer agent 139

Compound 6h (Anticancer Agent 139) is a potent tubulin-binding small molecule, engaging Lys352 via π-cation interaction. It demonstrates high growth inhibition in SNB-19, OVCAR-8, and NCI-H460 cells, with broader moderate activity across multiple other cancer cell lines, supporting its use in anticancer mechanism and cytotoxicity studies.